RTX Hybrid-Electric Flight Demonstrator program achieves full power test milestone for propulsion system and batteries
Prnewswire· 2025-06-16 13:00
Future flight-testing targets 30% improved fuel efficiency for regional turbopropsPARIS, June 16, 2025 /PRNewswire/ -- Pratt & Whitney Canada announces a new milestone in the RTX Hybrid-Electric Flight Demonstrator project, by testing the integrated propulsion system and batteries to full power. While ground testing of the hybrid-electric propulsion system continues in Longueuil, Quebec, Pratt & Whitney Canada has selected AeroTEC to support future flight testing of the De Havilland Canada Dash 8-100 experi ...
FingerMotion's Subsidiary JiuGe Technology and Qingling Motors Collaborate on Advancing Intelligent Vehicle Solutions
Newsfile· 2025-06-16 13:00
FingerMotion's Subsidiary JiuGe Technology and Qingling Motors Collaborate on Advancing Intelligent Vehicle SolutionsJune 16, 2025 9:00 AM EDT | Source: FingerMotion, Inc.Singapore, Singapore--(Newsfile Corp. - June 16, 2025) - FingerMotion, Inc. (NASDAQ: FNGR) ("FingerMotion" or the "Company"), a mobile services, data, and technology company, is pleased to announce that its subsidiary, Shanghai JiuGe Information Technology Co., Ltd. ("JiuGe Technology"), is working with Qingling Motors Group ...
Applied Materials and CEA-Leti Expand Joint Lab To Drive Innovation in Specialty Chips
Globenewswire· 2025-06-16 13:00
Based at CEA-Leti, Collaboration Focuses on Materials Engineering Solutions To Enable More Energy-Efficient AI Data CentersSANTA CLARA, Calif. and GRENOBLE, France, June 16, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. and CEA-Leti today announced the next phase of their longstanding collaboration to accelerate innovation in specialty semiconductors. Under a memorandum of understanding (MOU), the organizations plan to expand their joint lab and develop materials engineering solutions to address emerging ...
Meritage Homes Second Quarter 2025 Earnings Conference Call and Webcast Scheduled for July 24, 2025
Globenewswire· 2025-06-16 13:00
SCOTTSDALE, Ariz., June 16, 2025 (GLOBE NEWSWIRE) -- Meritage Homes Corporation (NYSE: MTH), the fifth largest public homebuilder in the U.S., plans to release the Company's second quarter 2025 results on Wednesday, July 23, 2025 after the market closes. Management will host a conference call to discuss the results at 8:00 a.m. Pacific Standard Time (11:00 a.m. Eastern Standard Time) on Thursday, July 24, 2025. To listen, please go to Meritage’s Investor Relations page for the live webcast or dial in to 1-8 ...
Truist names Charles Alston head of its new Nonprofit Hospitals, Higher Ed and Government banking team
Prnewswire· 2025-06-16 13:00
CHARLOTTE, N.C., June 16, 2025 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) today announced it has hired Charles Alston as head of its new Nonprofit Hospitals, Higher Education and Government (HHG) banking team to drive focused growth and deepen client relationships. Charles Alston As part of the Truist Specialized Industries team within the expanded Commercial and Corporate Banking business, HHG serves more than 1,000 clients that includes nonprofit hospitals, colleges and universities, an ...
Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnering Meetings at the 2025 BIO International Convention in Boston
Globenewswire· 2025-06-16 13:00
Ramat Gan, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer and inflammatory diseases, today announced that Dr. Sari Fishman, Vice President of Business Development, will present an update on the Company’s ongoing Phase IIa study in pancreatic cancer during partnering meetings at the 2025 BIO International Convention, taking place J ...
Android Auto™ Compatibility Now Available to Lucid Air Owners
Prnewswire· 2025-06-16 13:00
North American and European Lucid owners can now connect Android TM smartphones to the Lucid Air for an enhanced infotainment experienceNEWARK, Calif., June 16, 2025 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced electric vehicles, today announced that Android Auto Smart Driving Companion Application1 is now available in all Lucid Air vehicles via an over-the-air update to Lucid OS 2.7.0. Owners of the award-winning Lucid Air can now seamlessly access their favorite And ...
Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.
Globenewswire· 2025-06-16 13:00
XI’AN, China, June 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“Bon” or the “Company”), a leading bio-ingredient solutions provider for natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Tianjin Merrill-Youli Trading Co., Ltd., a prominent Asia-Pacific fragrance chemical distributor (“Merrill-Youli”). The term of the agreement is 36 months with a total contract value of up to US$18 million. Pursuant to the agreement, Merr ...
Opus One Gold Obtains 8.96 g/t Gold Over 5.2 m From 165 to 170.2 m Followed By 2.91 g/t Au Over 9.9 m From 179.2 to 189.1m From Hole No-25-14, at 200 Vertical Meters on Its Zone 1 Gold Discovery, Noyell Project and Appoints a New Director
Globenewswire· 2025-06-16 13:00
NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTREAL, June 16, 2025 (GLOBE NEWSWIRE) -- Opus One Gold Corp (TSX-V: OOR) (the “Company” or “Opus One”) is pleased to announce that drill hole NO-25-14 from the winter drilling program on its 100% owned Noyell project near the town of Matagami, Abitibi, Québec, Canada, returned 8.96g/t Au over 5.2 m from 165 to 170.2 m. The mineralized interval represents a true width of approximately 4.2 m within the Zone 1 structure. ...
Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year
Globenewswire· 2025-06-16 13:00
BOSTON and LONDON, June 16, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the IND to initiate a Phase 1 clinical study of ORX142 in healthy volunteers. ORX142 is an investigational, novel, highly potent and selective OX2R agonist being developed for the treatment of select neurological and neurodegenerative disorders. ORX142 is the second drug candidate from the Compa ...